Tubulointerstitial Nephritis Antigen-Like 1 (TINAGL1) (Middle Region) Peptid
TINAGL1
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle TINAGL1 Produkte
- TINAGL1 (Tubulointerstitial Nephritis Antigen-Like 1 (TINAGL1))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- ENGPVQALME VHEDFFLYKG GIYSHTPVSL GRPERYRRHG THSVKITGWG
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-TINAGL1 Antibody(ARP57622_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- TINAGL1 (Tubulointerstitial Nephritis Antigen-Like 1 (TINAGL1))
- Hintergrund
-
TINAGL1 may be implicated in the adrenocortical zonation and in mechanisms for repressing the CYP11B1 gene expression in adrenocortical cells. This is a non catalytic peptidase C1 family protein.
Alias Symbols: ARG1, LCN7, LIECG3, TINAGRP
Protein Interaction Partner: CAPN1,CAPN1,LMO4,MDFI,MED31,SMAD9,UTP14A,MDFI,MED31,UTP14A
Protein Size: 467 - Molekulargewicht
- 52 kDa
- Gen-ID
- 64129
- NCBI Accession
- NM_022164, NP_071447
- UniProt
- Q9GZM7
-
Sie sind hier:
